Detection of iron and zinc in human skin using non-invasive Raman spectrophotometer - A validation study among children under five years of age living in sub-Saharan Africa

This validation study in rural Burkina Faso and Kenya found that while the non-invasive Cell-/SO-Check Raman spectrophotometer is unsuitable for clinical diagnosis of iron and zinc deficiencies in children under five due to poor agreement with standard biomarkers, it may still be useful for ranking zinc status in population-based studies.

The Gist

Imagine you are trying to check if a car has enough oil and fuel without opening the hood or draining the tank. You'd love a magic wand that could just scan the outside of the car and tell you, "Hey, you're low on oil!" That is essentially what this study tried to do for children's nutrition.

Here is the story of the research, broken down into simple terms:

The Problem: The "Hidden Hunger"

In many parts of Sub-Saharan Africa, children often suffer from "hidden hunger." They might look okay on the outside, but they are missing tiny, crucial vitamins like Iron and Zinc. These are like the spark plugs and oil for the body's engine; without them, kids can't grow properly or fight off sickness.

Usually, to check for these missing vitamins, doctors have to stick a needle in a child's arm and draw blood. It's scary for the kids, painful for the parents, and requires expensive labs far away.

The New Idea: The "Nutrition Flashlight"

The researchers wanted to test a new gadget called the Cell-/SO-Check. Think of this device as a high-tech "nutrition flashlight." Instead of a needle, you just press it against a child's palm. It uses a special kind of light (Raman spectrometry) to "see" inside the skin and guess how much iron and zinc is stored there.

The big question was: Is this flashlight as good as the blood test?

The Experiment: The "Taste Test"

The team went to two places in Africa (Kenya and Burkina Faso) and tested 102 children.

1. They took a tiny bit of blood from each child (the "Gold Standard" or the truth).
2. They immediately used the handheld flashlight device on the child's palm.
3. They compared the two results to see if the flashlight matched the blood test.

The Results: A Mixed Bag

Here is where the story gets interesting. The results were like trying to use a weather app to predict the exact temperature of a specific cup of coffee.

1. The Iron Test (The "Broken Compass")

• What happened: The flashlight was very confused about Iron. It often said a child had plenty of iron when the blood test said they were starving for it, and vice versa.
• The Analogy: Imagine a compass that points North when you are actually in South America. It's not just slightly off; it's pointing in the wrong direction entirely.
• The Verdict: The device cannot be trusted to diagnose iron deficiency in individual children. It's too unreliable.

2. The Zinc Test (The "Good Gatekeeper")

• What happened: The flashlight was better at detecting Zinc, but it still had a bias (it tended to overestimate the numbers). However, it was very good at one specific thing: ruling out problems.
• The Analogy: Think of a security guard at a club. This device is great at saying, "You are definitely not on the banned list." If the device says a child has enough Zinc, you can be pretty sure they are fine. But if it says they are low, you can't be 100% sure; you'd still need to check with a blood test to be safe.
• The Verdict: It's a decent tool for screening large groups of people to see if a community might have a problem, but it's not good enough to diagnose a single sick child.

The Big Takeaway

The researchers concluded that while this handheld device is cool, safe, and painless, it is not ready to replace the blood test in a doctor's office.

• For Doctors: Stick with the blood test. It's the only way to be sure a specific child needs medicine.
• For Researchers: The device might still be useful for big surveys to get a rough idea of how a whole village is doing, as long as you know the numbers aren't perfect.

Why Does This Matter?

Even though the device didn't work perfectly yet, the study was important because it showed us that Iron and Zinc deficiency are still a huge problem in these communities. The blood tests confirmed that many children are indeed missing these nutrients.

The study is like a "proof of concept" that says: "We tried a new, painless way to check nutrition. It didn't work perfectly yet, but we learned a lot, and we know we need to keep inventing better tools to help these children grow up healthy."

Technical Summary

1. Problem Statement

Sub-Saharan Africa (SSA) faces a high burden of micronutrient deficiencies, particularly iron and zinc, which are exacerbated by climate change impacts on food security and infectious disease burdens. Current gold-standard diagnostic methods rely on invasive blood sampling (venous draws) and laboratory analysis (ELISA, atomic absorption spectroscopy). These methods are costly, require skilled personnel, and are difficult to implement in large-scale, remote, or resource-limited settings.

The study investigates the viability of handheld Raman spectrophotometry (specifically the Cell-/SO-Check device, ZellCheck®) as a non-invasive alternative. This technology claims to quantify intracellular stores of micronutrients by measuring light absorption/reflection at specific wavelengths on the skin. However, its validity for detecting iron and zinc status in young children in SSA had not been previously established against conventional laboratory biomarkers.

2. Methodology

Study Design & Population:

• Type: Validation study comparing a new diagnostic method against a gold standard.
• Setting: Health and Demographic Surveillance Systems (HDSS) in Siaya, Kenya, and Nouna, Burkina Faso.
• Participants: Children aged ≥24 months (recruited Sept–Oct 2020).
• Sample Size: 108 children recruited; 102 with demographic/anthropometric data; 72 children with complete paired data (spectrometer + lab) used for the final agreement and accuracy analysis.

Data Collection:

• Gold Standard (Laboratory):
  • Iron Status: Measured via Plasma Ferritin, Soluble Transferrin Receptor (sTfR), and C-reactive Protein (CRP) using ELISA. Deficiency was defined based on CRP-adjusted ferritin thresholds (<15 µg/L if CRP ≤5 mg/dL; <30 µg/L if CRP >5 mg/dL) or sTfR thresholds (>4.4 mg/L for females, >5.0 mg/L for males).
  • Zinc Status: Measured via plasma zinc concentration using atomic absorption spectroscopy. Deficiency defined as <7.7 µmol/L.
• Index Test (Spectrometer):
  • The Cell-/SO-Check device was applied to four points on the child's palm.
  • It emits light (tungsten diode and UV source) and detects characteristic frequencies to estimate micronutrient levels relative to a reference database of biopsies.
  • Outputs were rescaled to a 1–100 standard-unit range to facilitate comparison with laboratory values.

Statistical Analysis:

• Continuous Outcomes: Bland-Altman analysis to determine bias and 95% Limits of Agreement (LoA); Pearson correlation coefficients; Linear regression for proportional bias.
• Binary Outcomes (Deficiency): Receiver Operating Characteristic (ROC) curves to calculate Area Under the Curve (AUC), Sensitivity, Specificity, Positive Predictive Value (PPV), and Negative Predictive Value (NPV).

3. Key Contributions

• First Validation in SSA: This is the first study to validate the Cell-/SO-Check device specifically for iron and zinc detection in children under five in sub-Saharan Africa.
• Methodological Rigor: It provides a comprehensive statistical comparison (Bland-Altman, ROC, correlation) between a novel non-invasive optical method and established biochemical assays in a real-world, high-burden setting.
• Contextual Insights: The study highlights the impact of inflammation (high CRP levels in Kenya due to infectious disease ecology) on biomarker interpretation and the potential of non-invasive tools for population-level screening versus individual diagnosis.

4. Results

Demographics:

• Median age: 40 months; 53% male.
• Kenyan participants showed significantly higher CRP levels (median 2.8 mg/dL vs. 2.0 mg/dL in Burkina Faso), indicating a higher burden of inflammation/infection.

Agreement (Continuous Data):

• Correlation: There was no linear correlation between spectrometer readings and laboratory values for either zinc (r=0.03) or iron/ferritin (r=0.01).
• Bias & Limits of Agreement (LoA):
  • Iron (vs. Ferritin): High positive bias of 42.44 units. LoA ranged widely from -18.72 to 103.60.
  • Zinc: Positive bias of 7.48 units. LoA ranged from -49.26 to 64.23.
  • Interpretation: The wide LoA indicates poor agreement; the spectrometer consistently overestimates levels compared to the lab, but the error margin is too large for precise quantification.

Diagnostic Accuracy (Binary Deficiency):

• Iron Deficiency:
  • vs. Ferritin: AUC = 0.559 (no better than chance). Sensitivity 81.5%, Specificity 37.8%.
  • vs. sTfR: AUC = 0.617 (moderate). Sensitivity 68.0%, Specificity 55.3%.
• Zinc Deficiency:
  • vs. Atomic Absorption: AUC = 0.547 (no better than chance).
  • Sensitivity: Very low (33.3%).
  • Specificity: High (90.9%).
  • Predictive Values: Low PPV (25%) but high NPV (93.8%).

Prevalence Discrepancies:

• The spectrometer estimated iron deficiency at 13.9% (vs. ~29% by lab) and zinc deficiency at 23.6% (vs. 8.3% by lab), showing significant misclassification rates.

5. Significance and Conclusion

Clinical Implications:

• Not Suitable for Clinical Diagnosis: The study concludes that the handheld Raman spectrophotometer cannot replace standard laboratory measurements for diagnosing individual cases of iron or zinc deficiency due to poor correlation, high bias, and low diagnostic accuracy (AUC near 0.5).
• Potential for Screening/Ruling Out: The device showed high specificity for zinc (90.9%) and a high Negative Predictive Value (93.8%). This suggests it might be useful in population-based studies to rule out zinc deficiency (i.e., if the device says "no deficiency," the child likely does not have it), but it is unreliable for confirming deficiency.

Public Health & Research Implications:

• The study underscores the need for non-invasive tools that are not confounded by inflammatory states (like high CRP), which currently complicate iron biomarker interpretation.
• While the device failed to provide accurate absolute quantification, the authors suggest that with calibration adjustments, it could potentially be used for ranking populations by zinc status in epidemiological surveys, though not for individual clinical decision-making.
• The findings highlight the urgent need for continued investment in novel, non-invasive assessment methods that are robust against the high infectious disease burden typical of SSA.